Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
甲羟戊酸通路抑制剂的药物重新定位为卵巢癌的抗肿瘤药物
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.20046
Yusuke Kobayashi, Hiroyasu Kashima, Yohan Suryo Rahmanto, Kouji Banno, Yu Yu, Yusuke Matoba, Keiko Watanabe, Moito Iijima, Takashi Takeda, Haruko Kunitomi, Miho Iida, Masataka Adachi, Kanako Nakamura, Kosuke Tsuji, Kenta Masuda, Hiroyuki Nomura, Eiichiro Tominaga, Daisuke Aoki